JP2022514537A5 - - Google Patents
Info
- Publication number
- JP2022514537A5 JP2022514537A5 JP2021534215A JP2021534215A JP2022514537A5 JP 2022514537 A5 JP2022514537 A5 JP 2022514537A5 JP 2021534215 A JP2021534215 A JP 2021534215A JP 2021534215 A JP2021534215 A JP 2021534215A JP 2022514537 A5 JP2022514537 A5 JP 2022514537A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- acceptable salt
- salcardin
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862779056P | 2018-12-13 | 2018-12-13 | |
| US62/779,056 | 2018-12-13 | ||
| US201962858324P | 2019-06-06 | 2019-06-06 | |
| US62/858,324 | 2019-06-06 | ||
| PCT/US2019/066003 WO2020123824A1 (en) | 2018-12-13 | 2019-12-12 | Sulcardine administration for treatment of acute atrial fibrillation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022514537A JP2022514537A (ja) | 2022-02-14 |
| JP2022514537A5 true JP2022514537A5 (cg-RX-API-DMAC7.html) | 2022-12-19 |
Family
ID=69165588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021534215A Pending JP2022514537A (ja) | 2018-12-13 | 2019-12-12 | 急性心房細動の処置のためのサルカルディン投与 |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US11364223B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3893870A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022514537A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210135990A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113453677A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019397511B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3123078A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL283931A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021006933A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020123824A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202104166B (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020123824A1 (en) | 2018-12-13 | 2020-06-18 | Huya Bioscience International, Llc | Sulcardine administration for treatment of acute atrial fibrillation |
| KR102405199B1 (ko) | 2019-01-29 | 2022-06-02 | 후야 바이오사이언스 인터내셔널 엘엘씨 | 설카딘 염 |
| US11813245B2 (en) * | 2020-06-12 | 2023-11-14 | Huyabio International, Llc | Sulcardine administration for treatment of acute atrial fibrillation |
| CN114984004B (zh) * | 2022-05-25 | 2023-09-12 | 扬州中宝药业股份有限公司 | 硫酸舒欣啶在制备抗脓毒症药物中的应用 |
| WO2026036095A1 (en) * | 2024-08-08 | 2026-02-12 | Huyabio International, Llc | J-Tp PROTECTION |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1172908C (zh) | 1999-12-10 | 2004-10-27 | 中国科学院上海药物研究所 | N-取代苄基或苯基芳香磺酰胺化合物及其用途 |
| CN1939298A (zh) | 2005-09-29 | 2007-04-04 | 中国科学院上海药物研究所 | 硫酸舒欣啶固体和靶向制剂及其制备方法 |
| CN101484181B (zh) | 2006-06-30 | 2012-12-26 | 希格马托罕见疾病公司 | 用于生产l-天门冬酰胺酶ⅱ的重组宿主 |
| KR101491867B1 (ko) | 2007-01-31 | 2015-02-10 | 피페넥스 인크. | 증가된 발현을 위한 박테리아 리더 서열 |
| WO2011062903A2 (en) | 2009-11-17 | 2011-05-26 | Elliott Gary T | Slow infusion of sulcardine and its salts |
| US8541464B2 (en) * | 2009-11-17 | 2013-09-24 | HUYA Biosciences International LLC | Treatment of atrial fibrillation |
| WO2011126811A2 (en) | 2010-03-30 | 2011-10-13 | Pfenex Inc. | High level expression of recombinant toxin proteins |
| KR102092225B1 (ko) | 2014-04-30 | 2020-03-23 | 주식회사 엘지화학 | 고효율 분비능을 가지는 단백질 분비 인자 및 이를 포함하는 발현 벡터 |
| WO2016089782A1 (en) | 2014-12-01 | 2016-06-09 | Pfenex Inc. | Fusion partners for peptide production |
| EP3302442B1 (en) | 2015-06-03 | 2024-10-16 | Triastek, Inc. | Dosage forms and use thereof |
| AU2017261372B2 (en) | 2016-05-05 | 2019-02-14 | Triastek, Inc. | Controlled release dosage form |
| AU2018212273B2 (en) | 2017-01-26 | 2023-12-21 | Triastek, Inc. | Dosage forms of controlled release at specific gastrointestinal sites |
| WO2020123824A1 (en) | 2018-12-13 | 2020-06-18 | Huya Bioscience International, Llc | Sulcardine administration for treatment of acute atrial fibrillation |
| KR102405199B1 (ko) | 2019-01-29 | 2022-06-02 | 후야 바이오사이언스 인터내셔널 엘엘씨 | 설카딘 염 |
-
2019
- 2019-12-12 WO PCT/US2019/066003 patent/WO2020123824A1/en not_active Ceased
- 2019-12-12 CA CA3123078A patent/CA3123078A1/en active Pending
- 2019-12-12 US US16/712,677 patent/US11364223B2/en active Active
- 2019-12-12 MX MX2021006933A patent/MX2021006933A/es unknown
- 2019-12-12 CN CN201980092127.1A patent/CN113453677A/zh active Pending
- 2019-12-12 AU AU2019397511A patent/AU2019397511B2/en active Active
- 2019-12-12 KR KR1020217021861A patent/KR20210135990A/ko not_active Ceased
- 2019-12-12 JP JP2021534215A patent/JP2022514537A/ja active Pending
- 2019-12-12 EP EP19836740.1A patent/EP3893870A1/en active Pending
-
2021
- 2021-06-13 IL IL283931A patent/IL283931A/en unknown
- 2021-06-17 ZA ZA2021/04166A patent/ZA202104166B/en unknown
-
2022
- 2022-05-23 US US17/750,944 patent/US11883380B2/en active Active
-
2023
- 2023-12-19 US US18/545,558 patent/US12357611B2/en active Active
-
2025
- 2025-06-16 US US19/239,746 patent/US20250302805A1/en active Pending